There has been a warning from U.S. regulators diabetes drug Avandia to a few instance of swelling in the back of the eye as of last week.
The FDA issued a notice last week after GSK said it had received "very rare" reports of the swelling (macular oedema).
The warning also applies to Avandamet, a combination product (with the same active ingredient).
- From the FDA web site.
